Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




POC Diagnostic Platform Combines Immunoassay and Molecular Testing

By LabMedica International staff writers
Posted on 14 May 2025

An innovative diagnostic platform offers superior sensitivity across all sample types, including blood, compared to existing rapid tests, while maintaining a low-cost, user-friendly design. More...

This platform not only demonstrates true lab-quality sensitivity, even with the most challenging clinical samples, but also maintains low invalid rates and minimal system downtime.

Cubit Diagnostics (Carlsbad, CA, USA) is further advancing the development of its integrated immunoassay and molecular benchtop analyzer, specifically designed for use in doctor’s offices and pharmacies, eliminating the need for multiple platforms and complicated testing workflows. The Cubit platform leverages a proprietary purification method and affordable microfluidic technologies to provide actionable results exactly when and where they are needed. By integrating cutting-edge target extraction technology with a simple, cost-effective design, CubitDx is addressing long-standing challenges in diagnostics. The result is laboratory-grade performance without sacrificing affordability, supporting the increasing trend of digital health and enabling more accessible care. The platform can simultaneously test up to 8 targets per run, offering comprehensive syndromic testing while performing both immunoassays and molecular testing on a single platform.

While initially focused on COVID-19, Flu A, and Flu B, the CubitDx platform is designed to tackle a wide range of critical health issues, including sepsis, sexually transmitted diseases (STDs), HIV, and HPV in the future. Evaluation results show that the CubitDx platform’s COVID-19 assay provides higher sensitivity than standard rapid tests and matches the sensitivity of large, high-throughput clinical laboratory systems. With the ability to deliver lab-quality results in just 15 minutes at the point of care, the platform aims to bring high-performance diagnostics closer to patients, improving both outcomes and accessibility worldwide. Offering affordable, high-sensitivity diagnostics for both resource-rich and cost-sensitive markets, the CubitDx platform has the potential to revolutionize healthcare access globally, from U.S. hospitals to underserved communities across Asia and Africa.

Related Links:
Cubit Diagnostics


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.